In the Age of Personalized Medicine and Right to Try, Have Big Clinical Trials Become Obsolete?
An opinion piece in the Wall Street Journal this week raises an interesting question: is the era of large Phase 3 clinical trials coming to an end. It is a reasonable argument that when treatments can be customized to patients via personalized therapies, and the benefit of a new drug can be supported by real … Read more